Press "Enter" to skip to content

Cancer Drug Market is valued at USD 95.24 Billion in 2018 and expected to reach USD 166.43 Billion by 2025 with a CAGR of 8.3%

Cancer Drug Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025- Increasing prevalence of cancer is the key driving factor for the growth of Global Cancer Drug Market.

Cancer Drug Market is valued at USD 95.24 Billion in 2018 and expected to reach USD 166.43 Billion by 2025 with a CAGR of 8.3% over the forecast period.

Scope of Global Cancer Drug  Market Reports –

Cancer is an illness, which includes the irregular development of cells that outcome in the arrangement of a tumor. Cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer.  Various kinds of cancer growths, for example, lung disease, colorectal, bosom disease, and others are dominating among the masses. Drugs used to treat cancer are also called anticancer medications or anticancer agents. There are several types of cancer drugs present in the market such as alkylating agents, antimetabolites, anti-tumor antibiotics, topoisomerase. Chemotherapy is a type of cancer treatment that uses drugs to kill cancer cells. Global cancer drug market is expected to witness a significant growth owing to flood in diseases exploral, ascend in geriatric populations around the world, and increment in the number of coordinated efforts between pharmaceutical organization.

Global cancer drugs market report is segmented on the basis of type, applications, and region & country level. Based upon type, cancer drug market is segmented into chemotherapy, targeted therapy, immunotherapy, and hormonal therapy. Based upon applications, cancer drug is segmented into lung cancer, stomach cancer, colorectal cancer, breast cancer, prostate cancer, liver cancer, esophagus cancer, cervical cancer, kidney cancer, bladder cancer and others.

Browse The Full Report@ https://www.brandessenceresearch.com/healthcare/cancer-drug-market/

The regions covered in Global Cancer Drug Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Cancer Drugs market is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Cancer Drug Market Report

Some major key players for global Cancer Drug market are AbbVie Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Celgene Corporation, f. Hoffmann-La Roche ltd., Johnson and Johnson (Janssen Global Services, LLC), Merck and Co, Inc., Novartis AG, Pfizer Inc. and others.

News:

May, 2019, A £75m investment to develop the drugs has been announced by the Institute of Cancer Research (ICR). The new drugs could make cancer a “manageable” disease in the long term and “more often curable. Researchers said that existing treatments such as chemotherapy sometimes fail because the deadliest cancer cells adapt and survive, causing the patient to relapse. The ICR aims to attract a further £15m of funding for its new Centre for Drug Discovery at its campus in Sutton, south London, which is intended to bring together almost 300 scientists from different fields.

Increasing Prevalence of Cancer Across the Globe is Expected to Drive the Global Cancer Drug Market.

Increasing prevalence of cancer coupled with the increasing geriatric population is one of the major factors driving the growth of global cancer drug market. According to Population Reference Bureau; in U.S. the figure of Americans ages 65 and older is projected to more than double from 46 million recently to over 98 million by 2060, and the 65-and-older age group’s share of the total population will rise to nearly 24 percent from 15 percent. In addition, increasing tobacco consumption and rising disposable income are also anticipated to supplement the growth of cancer drug market. Furthermore, increasing healthcare spending and technological advancements in this field are also anticipated to foster the growth of cancer drug market over the forecast period. However, adverse effects associated with the use of cancer drugs may hamper the growth of this market within the forecast period. Moreover, increase in number of pipeline drugs may provide lucrative opportunities for cancer drugs market growth.

North America is Expected to Dominate the Cancer Drug Market:

The cancer drug market is segmented into North America, Europe, Asia-Pacific, Latin America and Rest of the World (ROW). North America holds largest share of global cancer drug market. According to American Association for Cancer Research; as of January 1, 2012, approximately 13.7 million cancer fighters were living in the United States with prevalence projected to approach 18 million by 2022. 64% percent of this population have survived 5 years or more; 40% have lived 10 years or more; and 15% have survived 20 years or more after diagnosis. Over the next decade, the number of people who have lived 5 years or more after their cancer diagnosis is projected to increase approximately 37% to 11.9 million. Asia Pacific is expected to witness to grow at highest CAGR owing to the growing awareness regarding the cancer drugs and increasing disposable income in this region within the forecast period.

Key Benefits for Global Cancer Drug Market Report –

  • Global Cancer Drug Market report covers in-depth historical and forecast analysis.
  • Global Cancer Drug Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
  • Global Cancer Drug Market report helps to identify opportunities in marketplace.
  • Global Cancer Drug Market report covers extensive analysis of emerging trends and competitive landscape.

Cancer Drug Market Segmentation:–

By Drug Class Type

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy (Biologic Therapy)
  • Hormonal Therapy

By Application

  • Lung Cancer
  • Stomach Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Prostate Cancer
  • Liver Cancer
  • Esophagus Cancer
  • Cervical Cancer
  • Kidney Cancer
  • Bladder Cancer
  • Other Cancers

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • UK.
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

About Us: Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us at sales@brandessenceresearch.com